Dr. George Jallo

Dr. Jallo is the vice dean and physician-in-chief at Johns Hopkins All Children's Hospital. He also is the David M. Goldenberg Family Endowed Chair in the Institute for Brain Protection Sciences and a professor of neurosurgery, pediatrics and oncology with Johns Hopkins University School of Medicine. Dr. Jallo joined Johns Hopkins in 2003 as a pediatric neurosurgeon. In 2013, he became the pediatric neurosurgery division director at The Johns Hopkins Hospital in Baltimore. Dr. Jallo moved to Johns Hopkins All Children's in 2015 to launch the Institute for Brain Protection Sciences, a multidisciplinary institute that unites clinicians, researchers and educators focused on promoting optimal neurodevelopment and caring for children with injuries and illnesses that can affect the brain. His areas of expertise include tumors of the brain and spinal cord, intraoperative neurophysiological monitoring for eloquent tumors, use of minimally invasive technologies such as endoscopy and keyhole surgery and surgical treatment of epilepsy. Dr. Jallo has published more than 245 peer-reviewed scientific articles, 89 book chapters and is co-editor of five textbooks on pediatric neurosurgery, pediatric epilepsy surgery and neuroendoscopy. In addition, Dr. Jallo has been principal investigator for NIH and private foundation grants focused on treatment of pediatric central nervous system tumors and other neurosurgical challenges. Dr. Jallo earned his medical degree at the University of Virginia Medical School and completed his residency in neurosurgery at New York University Medical Center and fellowship in pediatric neurosurgery at Beth Israel Medical Center, Institute for Neurology and Neurosurgery, in New York.

Dr. Jallo is highly rated in 26 conditions, according to our data. His top areas of expertise are Ependymoma, Spinal Tumor, Subependymoma, Posterior Fossa Decompression, and Laminectomy.

His clinical research consists of co-authoring 184 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.